iOx Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| IMM60 and Pembrolizumab in Melanoma and NSCLC (NCT05709821) | iOx Therapeutics | 2023-11-15 |
Track iOx Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.